A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2017-03-15
Target enrollment:
Participant gender:
Summary
This is a four-way crossover (non-parallel) study with each subject receiving three of the
four arms. The study will enroll approximately 30 adult subjects with T2DM from age 20 to 75
inclusive.
Following a 7-10 day Screening period, eligible subjects will enter a 3-day single-blind
placebo run-in. On Day 4, each subject will be randomized to a treatment sequence that will
include three treatment assignments for each of three treatment Periods according to the
randomization scheme.